Prevention of high- and low-dose STZ-induced diabetes with D-glucose and 5-thio-D-glucose

Prevention of high- and low-dose STZ-induced diabetes with D-glucose and 5-thio-D-glucose. Z Wang , C Dohle , J Friemann , B S Green and H Gleichmann Clinical Department, Heinrich-Heine-University of Düsseldorf, Germany. Abstract To induce hyperglycemia in mice by administration of STZ, two experime...

Full description

Saved in:
Bibliographic Details
Published inDiabetes (New York, N.Y.) Vol. 42; no. 3; pp. 420 - 428
Main Authors Wang, Z., Dohle, C., Friemann, J., Green, B. S., Gleichmann, H.
Format Journal Article
LanguageEnglish
Published American Diabetes Association 01.03.1993
Online AccessGet full text

Cover

Loading…
More Information
Summary:Prevention of high- and low-dose STZ-induced diabetes with D-glucose and 5-thio-D-glucose. Z Wang , C Dohle , J Friemann , B S Green and H Gleichmann Clinical Department, Heinrich-Heine-University of Düsseldorf, Germany. Abstract To induce hyperglycemia in mice by administration of STZ, two experimental protocols that involve different pathogenic pathways are being used. First, the intraperitoneal injection of a single high dose (HD-STZ) exerts direct toxicity on beta-cells, which results in necrosis within 48-72 h and overt permanent hyperglycemia. Second, injections of multiple low doses of STZ (LD-STZ), administered intraperitoneally on 5 consecutive days, induce both beta-cytotoxic effects and STZ-specific T-cell-dependent immune reactions. In LD-STZ models, only a combination of toxic and immunological effects result in gradually increasing hyperglycemia, provided male mice of susceptible strains are being used. In this study, we found that 5-T-G, a glucose analogue that has sulfur for oxygen in the pyranose ring, prevented, in a dose-dependent way, both HD-STZ- and LD-STZ-induced hyperglycemia and that D-G, which was only tested in the LD-STZ system, was also protective, albeit somewhat less so than 5-T-G. This protective effect was achieved by intraperitoneally injecting 5-T-G and D-G, respectively, right before each STZ injection. Protection against hyperglycemia was already achieved with a total of 3 injections of 5-T-G, 1 injection each given before the first 3 of 5 LD-STZ injections. By means of OGTT, it was determined that pretreatment with 5-T-G afforded protection from substantial beta-cell damage in vivo.
ISSN:0012-1797
1939-327X
0012-1797
DOI:10.2337/diabetes.42.3.420